1. Home
  2. Health Care
  3. Austin, TX
  4. Clinical Data Interchange Standards Consortium

Clinical Data Interchange Standards Consortium

Clinical Data Interchange Standards Consortium has an America's Best Score of 41 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • Austin, TX
  • Tax-exempt since 2011
  • EIN: 04-3503931
cdisc.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
41OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Clinical Data Interchange Standards Consortium is a 501(c)(3) organization, classified under Health Care (NTEE E052). Contributions are tax-deductible.

7500 Rialto Blvd Ste 1-250, Austin, TX 78735-8556

Among the 51 scored health care organizations in Austin, Clinical Data Interchange Standards Consortium holds 2.5 months of operating reserves (peer median 6.5 months), runs a typical yearly deficit of 9.3% (peers: surplus of 4.8%), and has cut spending 4.1% a year (peers: grown spending 9.4% a year).

In fiscal year 2025 it reported $8,901,903 in revenue and $8,480,440 in expenses, with contributions making up 51.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

To create connected standards across the study information lifecycle to enable accessible, interoperable, and reuable data for more meaningful and effective research.

Largest programs · fiscal year 2025

  • In 2024, cdisc introduced a strategic roadmap to expand and enable standards driven automation across the end-to-end study information lifecycle from study design through results. To realize this vision, cdisc is mobilizing its work around three key pillars: Expand & connect, enable & automate, and engage & adopt. These three strategic pillars position cdisc and the industry for future innovation… Read more

    In 2024, cdisc introduced a strategic roadmap to expand and enable standards driven automation across the end-to-end study information lifecycle from study design through results. To realize this vision, cdisc is mobilizing its work around three key pillars: Expand & connect, enable & automate, and engage & adopt. These three strategic pillars position cdisc and the industry for future innovation and transformation. With expand & connect, we aim to embrace and adopt digital study design, creating connected standards across the clinical research information lifecycle while defining a clear pipeline for integrating new data sources. Through enable & automate, we develop ready-to-use implementation standards that are enabled through technology, reduce variability and focused on interoperability and automation. Finally, engage & adopt establishes a continuous feedback loop across the cdisc community, prioritizing the needs of producers and consumers to lower the barrier to standards use, and increasing communication to better enable our stakeholders.this year, as we celebrated our 25th anniversary highlighting key partnerships, volunteers and impact. We initiated and advanced 360i, moving the industry toward a dynamic and standards-driven data flow with over 80+ contributors leading teams (design, build, and run), innovation challenges, and roundtables to shape the future of clinical research. The design team developed detailed user stories spanning from study design through study amendment and demonstrated the ability to leverage the digital protocol to automate downstream. A key achievement was embedding conformance considerations from the outset, using core and cdisc open rules to ensure standards conformance throughout the lifecycle. The build team successfully generated define.xml and shell datasets from the digital protocol identifying the metadata needed for automation. The run team demonstrated the ability to process data from a wide range of sources (e.g., crf, fhir rwd, dht) and leveraging open source tools to automate the generation of sdtm data sets from upstream digital study design information. Strategic collaborations strengthened this momentum, supporting modernization, expanding digital standards, and improving interoperability across study startup and data exchange. Our events and education offerings also saw strong engagement, building skills, expanding understanding, and fostering deeper alignment across the community.2025 technical milestones: -Ai innovation challenge launched to galvanize global innovators to advance the digitization and automation of clinical research through ai, ml, and cdisc standards. With 22 submissions across three technically complex use cases, the challenge delivered practical, standards-driven solutions that strengthen interoperability, accelerate digital protocol development, and enable end-to-end traceability. -Cdisc open source alliance (cosa) partnered across the global community met quarterly throughout the year to showcase their open-source solutions including hackathons and more than 15 open source solution demos and 8 oss additions to the repository. -Technology vendor roundtable initiated to bring together cdisc members focusing on technology solutions in a collaborative environment to support cdisc's digital transformation. Participants discussed the future of clinical trial innovation by ensuring that cdisc standards are practical and implementable in modern digital workflows. It supports the broader 360i initiative by helping vendors and developers discuss tools that integrate seamlessly with cdisc's structured metadata and digital protocol models. -Tmf marked a major milestone as it became the official cdisc tmf standard, transforming tmf rm v4 into version 1 of a unified, interoperable framework for clinical trial documentation. Additionally, the global tmf community advanced into the collaborative cdisc tmf community, embracing a data-driven, machine-readable future that will enable decentralized trials, real-time oversight, and streamlined compliance -unified study definitions model v4.0 includes an implementation guide, logical model, controlled terminology, api specifications, conformance rules to support usage of usdm. Usdm v3.0 conformance rule specs provides the technical guidance used to assert that any given study definition solution conforms to usdm v3.0. -Cardiac imaging supplement to the duchenne muscular dystrophy ta user guide v1.0 developed in partnership with the c-path duchenne regulatory science consortium (d-rsc), the supplement to the dmd taug includes new controlled terminology, and sdtm and adam examples for cardiovascular tests. -Define-xml v2.1.8 & v2.1.9 releases includes the define-enumerations schema file that reflects the release of ct p59. -Cdisc open rules engine (core) v0.14.0 enables jsonata rules (usdm conformance rules). -Ct relationships v1.0 for sdtm v1.7, sdtmig v3.3, sdtmig-md v1.1 defines relationships between published ct codelists/terminology subsets and the cdisc variables, tests, parameters, and non-standard variables (nsvs) published in sdtmigs, taugs, and regulatory documents. -Biomedical concepts browser allows users to efficiently search, filter, and locate the latest bcs and sdtm dataset specializations in the cdisc library. -Qrs portal features qrs packages of machine-readable content including bcs, sdtm ct, sdtm dataset specializations, and odm files; 2 packages released; 18 qrs supplements released. -Ecrf portal consists of ready-to-use, cdash-compliant, annotated ecrfs, available in pdf, html and xml formats

    $4,629,083 spent · 75.8% of program spending
  • Education - in 2025 cdisc education trained 800 individuals with expanded education offerings including 8 new trainings, equipping the global cdisc community with practical tools and knowledge to implement standards more effectively. Instructors led 77 trainings for trainees from 130+ organizations representing 35 countries. $603,022 spent · 9.9% of program spending
  • Events - cdisc held 7 global events (united states, switzerland, japan, china, korea and india) across three continents with more than 1,400+ attendees fostered collaboration and knowledge sharing across the clinical research community gathering to network, share their expertise, best practices, and lessons learned about leveraging cdisc standards to bring efficiencies and clarity to data. 2025 Br… Read more

    Events - cdisc held 7 global events (united states, switzerland, japan, china, korea and india) across three continents with more than 1,400+ attendees fostered collaboration and knowledge sharing across the clinical research community gathering to network, share their expertise, best practices, and lessons learned about leveraging cdisc standards to bring efficiencies and clarity to data. 2025 Brought together professionals from a wide range of roles, including managers, directors, operations experts, and executives. This diverse attendee base reflects our ability to engage leaders and practitioners alike, fostering meaningful dialogue and collaboration across all levels of the industry. Attendees participated from various organizations in pharmaceutical, cro, technology, academic and research institutions. Cdisc also supported external events throughout the year with our partner organizations.

    $857,770 spent · 14.1% of program spending
  • Partnerships & collaboration cdisc has over 400 member organizations across 27 countries. Our impact as an organization is multiplied by our collaborations with our global partners including regulatory agencies and patient foundations. Through partnership, we can continue to advance interoperable standards across a wide range of therapeutic areas so greater clarity is achieved, more powerful resea… Read more

    Partnerships & collaboration cdisc has over 400 member organizations across 27 countries. Our impact as an organization is multiplied by our collaborations with our global partners including regulatory agencies and patient foundations. Through partnership, we can continue to advance interoperable standards across a wide range of therapeutic areas so greater clarity is achieved, more powerful research is conducted, and more meaningful connections are discovered. And as our dedication and collaboration continue to grow, so too will our collective impact on global health.

    $14,310 spent · 0.2% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 72¢ went to programs, 23¢ to management and 5¢ to fundraising.

  • Programs $6,104,185
  • Management $1,992,655
  • Fundraising $383,600

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score41 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves2.5 mo; 3.3 mo in cash1.8 / 25
Financial balance (median margin)−9.3%7.3 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth−4.1% / yr5.5 / 15
Track record15 years6 / 10
Debt load55.6% of assets0.9 / 10
Total41.4 → 41
Spending on programs
Not scored; America's Best needs 65%+
72%Meets

Compared with Austin peers

MeasureThis organizationPeer median
Operating reserves2.5 mo6.5 mo
Typical margin−9.3%+4.8%
Spending growth−4.1% / yr+9.4% / yr
Debt load55.6%15.5%

Peers: the 51 Austin health care organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$8,901,903Fiscal year 20252022: $8,105,54320222023: $9,333,12820232024: $9,205,90520242025: $8,901,9032025
Expenses$8,480,440Fiscal year 20252022: $9,610,01520222023: $11,224,77920232024: $9,491,93920242025: $8,480,4402025
Total assets$3,998,049Fiscal year 20252022: $5,085,70120222023: $3,979,56920232024: $3,169,76420242025: $3,998,0492025
Total liabilities$2,221,453Fiscal year 20252022: $1,515,40820222023: $2,300,92720232024: $1,777,15620242025: $2,221,4532025
Fiscal year ending December 2025
Revenue$8,901,903
Expenses$8,480,440
Net income$421,463
Net assets$1,776,596

Notable sources of revenue

Percent of total revenue
Contributions$4,581,730
Program services$4,289,736
Investment income$30,437
Other (net)$0

Assets / debt

Total assets$3,998,049
Total liabilities$2,221,453
Net assets$1,776,596

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$9,205,905
Expenses$9,491,939
Net income−$286,034
Net assets$1,392,608

Notable sources of revenue

Percent of total revenue
Contributions$4,558,549
Program services$4,608,298
Investment income$39,058
Other (net)$0

Assets / debt

Total assets$3,169,764
Total liabilities$1,777,156
Net assets$1,392,608

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$9,333,128
Expenses$11,224,779
Net income−$1,891,651
Net assets$1,678,642

Notable sources of revenue

Percent of total revenue
Contributions$4,791,339
Program services$4,513,613
Investment income$28,176
Other (net)$0

Assets / debt

Total assets$3,979,569
Total liabilities$2,300,927
Net assets$1,678,642

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$8,105,543
Expenses$9,610,015
Net income−$1,504,472
Net assets$3,570,293

Notable sources of revenue

Percent of total revenue
Contributions$4,130,952
Program services$3,935,285
Investment income$39,306
Other (net)$0

Assets / debt

Total assets$5,085,701
Total liabilities$1,515,408
Net assets$3,570,293

Compensation

Officers and key employees$1,346,011
Share of expenses14.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?